More specifically, mutations in the genes involved in the NFκB signaling pathway and in PIM1, as observed in PCNSL, are likely associated with the activated B-cell like (ABC) subtype of DLBCL. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.